A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder
Clinical trial NCT00236379 · COMPLETED
Trial details
- NCT number
- NCT00236379
- Sponsor
- Janssen, LP
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.